• Japanese
  • Korean
  • Chinese
Cover Image

Thromboembolism Global Clinical Trials Review, H2, 2013

GlobalData's clinical trial report, "Thromboembolism Global Clinical Trials Review, H2, 2013" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Thromboembolism
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Thromboembolism
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Thromboembolism Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • The LEO Foundation
      • Clinical Trial Overview of The LEO Foundation
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
      • Beijing Chao Yang Hospital
      • Clinical Trial Overview of Beijing Chao Yang Hospital
      • University of Zurich
      • Clinical Trial Overview of University of Zurich
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Capital District Health Authority, Canada
      • Clinical Trial Overview of Capital District Health Authority, Canada
      • McMaster University
      • Clinical Trial Overview of McMaster University
      • Centre Hospitalier Universitaire de Saint Etienne
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
      • Universita di Padova
      • Clinical Trial Overview of Universita di Padova
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013*
  • Thromboembolism Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Thromboembolism Therapeutics Clinical Trials, G7 Countries, 2013*
  • Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Thromboembolism Therapeutics Clinical Trials, E7 Countries, 2013*
  • Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Thromboembolism Therapeutics Market, Global, Suspended Clinical Trials, 2013*
  • Thromboembolism Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
  • Thromboembolism Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Chao Yang Hospital, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2013*
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita di Padova, 2013*

List of Figures

  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
  • Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013*
  • Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013*
  • Thromboembolism Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Thromboembolism Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Thromboembolism Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Show More
Pricing